About this trial
In a prospective cohort study (n = 1.000), the investigators aim to investigate the correlation between cardiac biomarkers and advanced echocardiography and determine whether these are prognostic markers of heart disease in patients suffering from psoriasis.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients 18 years or older with a diagnosis of psoriasis will be invited to participate
Disqualifiers
Patients not able to cooperate to the study
Patients unable understand and sign informed consent
Trial population
Psoriasis patients will be recruited prospectively from the Outpatient Clinic, Department of Dermato- Allergology, Herlev and Gentofte University Hospital, and Bispebjerg \& Frederiksberg Hospital, Denmark. Eligible psoriasis patients will be identified from the daily outpatient program, at the Department of Dermato-Allergology. As most outpatient clinic psoriasis is classified as moderate to severe, in order to approximate a random sample as accurate as possible including patients with mild psoriasis, all people with a diagnosis of psoriasis will a general invitation to participate in the study through appropriate channels such as the Danish Psoriasis Foundation's newsletter.
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Cardiovascular mortality
Cardiovascular mortality
Cardiovascular mortality
Myocardial infarction
Secondary outcomes
All-cause mortality
All-cause mortality
All-cause mortality
Admission with cardiac heart failure (CHF)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.